Your Location：Home - News Updates > - Content
News and Information
Guizhou Seeks to Take Lead in Advancing China’s Healthcare Industry
Time：2016-09-22 15:49:01
Source：US-China Health Magazine
Holding the country's big data hub promise, Southwest China's Guizhou Province is stepping up efforts to build a complete big health industrial chain shored up by medicine, healthcare, sports and management to attain complementary growth in the big health and big data sectors.
Developing the healthcare industry is one of the biggest tasks and challenges facing China during its economic transformation, said Chi Fulin, director of the China (Hainan) Institute for Reform and Development. The country will witness its healthcare sector grow faster than in any other place in the world over the next 10 years.
The changes in the consumption structure and the demand structure of urban and rural areas, as well as the increasingly aging population have triggered the need to promote the growth of the health sector, Chi said.
The fair, which kicked off on Friday in Guiyang, capital of Guizhou Province, attracted about 2,500 companies from both home and abroad. At the opening ceremony, the companies signed deals for 38 health and pharmaceutical projects worth some 20.59 billion yuan ($3.08 billion).
Developing the healthcare industry is one of the biggest tasks and challenges facing China during its economic transformation, said Chi Fulin, director of the China (Hainan) Institute for Reform and Development. The country will witness its healthcare sector grow faster than in any other place in the world over the next 10 years.
The changes in the consumption structure and the demand structure of urban and rural areas, as well as the increasingly aging population have triggered the need to promote the growth of the health sector, Chi said.
The fair, which kicked off on Friday in Guiyang, capital of Guizhou Province, attracted about 2,500 companies from both home and abroad. At the opening ceremony, the companies signed deals for 38 health and pharmaceutical projects worth some 20.59 billion yuan ($3.08 billion).
